Recent 8-K filings for CNXU

• July 7, 2026, 5:12 PM ET other material materiality 0.60 positive item 7.01item 9.01

  Conexeu Sciences completes 12-month preclinical P.R.O.O.F study for CXU platform

  12-month preclinical study met objectives for tissue restoration in cheek and 200cc-equivalent models.

• June 9, 2026, 4:30 PM ET other material materiality 0.25 neutral item 3.02item 9.01 ◈ Equity Issuances ×3

  Conexeu Sciences raises ~$167K through warrant exercises, issues 516,667 shares

  On June 4, 2026, issued 416,667 shares upon warrant exercise, gross proceeds ~$166,667.

• May 15, 2026, 4:22 PM ET other material materiality 0.55 neutral item 3.02item 5.03item 9.01 ◈ Governance Changes

  Conexeu Sciences issues 4.34M shares on warrant exercise, raises ~$1.96M; amends bylaws to increase quorum

  Issued 4,342,648 common shares upon exercise of warrants for aggregate gross proceeds of ~$1,963,967.

Materiality & sentiment trend

Max materiality 0.60 · Median 0.55 · Most common event other_material

1 positive 0 negative 2 neutral

source · CNXU on sec.gov